摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-bromo-1-(but-2-ynyl)-6-naphth-1-ylmethyl-5,6-dihydro-1H-imidazo[4,5-d]pyridazine-4,7-dione | 864673-16-5

中文名称
——
中文别名
——
英文名称
2-bromo-1-(but-2-ynyl)-6-naphth-1-ylmethyl-5,6-dihydro-1H-imidazo[4,5-d]pyridazine-4,7-dione
英文别名
2-bromo-3-but-2-ynyl-5-(naphthalen-1-ylmethyl)-6H-imidazo[4,5-d]pyridazine-4,7-dione
2-bromo-1-(but-2-ynyl)-6-naphth-1-ylmethyl-5,6-dihydro-1H-imidazo[4,5-d]pyridazine-4,7-dione化学式
CAS
864673-16-5
化学式
C20H15BrN4O2
mdl
——
分子量
423.269
InChiKey
SDLOGRJDNORAQQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    27
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    67.2
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
    申请人:Eckhardt Matthias
    公开号:US20050203095A1
    公开(公告)日:2005-09-15
    The invention relates to substituted imidazopyridazinediones of general formula wherein R 1 and R 4 are defined as in claim 1, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    这项发明涉及一般式的取代咪唑吡啶二酮,其中R1和R4如权利要求1中定义,其互变异构体、对映体、非对映体、其混合物及其盐具有有价值的药理特性,特别是对酶二肽基肽酶-IV(DPP-IV)活性的抑制作用。
  • Imidazopyridazinediones, Their Preparation And Their Use As Pharmaceutical Compositions
    申请人:Eckhardt Matthias
    公开号:US20070142383A1
    公开(公告)日:2007-06-21
    The invention relates to substituted imidazopyridazinediones of general formula wherein R 1 to R 4 are defined as in claim 1 , the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及一种通式为R1至R4如权利要求1所定义的取代咪唑吡啶二酮,其互变异构体、对映异构体、顺反异构体、混合物及其盐具有有价值的药理学性质,尤其是对二肽基肽酶IV(DPP-IV)酶活性具有抑制作用。
  • US7393847B2
    申请人:——
    公开号:US7393847B2
    公开(公告)日:2008-07-01
  • US7432262B2
    申请人:——
    公开号:US7432262B2
    公开(公告)日:2008-10-07
  • 3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitors
    作者:Matthias Eckhardt、Norbert Hauel、Frank Himmelsbach、Elke Langkopf、Herbert Nar、Michael Mark、Moh Tadayyon、Leo Thomas、Brian Guth、Ralf Lotz
    DOI:10.1016/j.bmcl.2008.04.075
    日期:2008.6
    Systematic variations of the xanthine scaffold in close analogs of development compound BI 1356 led to the class of 3,5-dihydro-imidazo[4,5-d]pyridazin-4-ones which provided, after substituent screening, a series of highly potent DPP-4 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多